This inventor holds 1 USPTO granted patent. Top assignee: Henry Ford Health System. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Ana Decarvalho: Innovator in Glioblastoma Treatment
Introduction
Ana Decarvalho is a prominent inventor based in Detroit, MI (US). She has made significant contributions to the field of oncology, particularly in the treatment of glioblastoma. Her innovative approach focuses on targeting patient-specific oncogenes in extrachromosomal DNA.
Latest Patents
Ana holds a patent for a groundbreaking method titled "A Method of Targeting Patient-Specific Oncogenes in Extrachromosomal DNA to Treat Glioblastoma." This patent represents her commitment to advancing cancer treatment and improving patient outcomes. She has 1 patent to her name.
Career Highlights
Ana Decarvalho is affiliated with the Henry Ford Health System, where she applies her expertise in oncology research. Her work is instrumental in developing new therapeutic strategies for patients suffering from glioblastoma.
Collaborations
Ana collaborates with esteemed colleagues, including Roel Verhaak and Hoon Kim, to further her research and enhance the impact of her innovations.
Conclusion
Ana Decarvalho is a trailblazer in the field of oncology, dedicated to improving treatment options for glioblastoma patients. Her innovative methods and collaborative efforts are paving the way for future advancements in cancer therapy.